KRAS & NRAS gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen

Preferred Label : KRAS & NRAS gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen;

LOINC status : ACTIVE;

LOINC display name : KRAS and NRAS gene targeted mutation analysis Molgen Nom (Bld/Tiss);

LOINC long common name : KRAS and NRAS gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal;

LOINC short name : KRAS NRAS Mut Anl Bld/T;

LOINC description : This assay will detect mutations in exons 2, 3 and 4 of both the KRAS and NRAS genes, allowing the determination of drug response. This term was created for, but not limited in use to, the ABI PRISM SNaPshot Multiplex Kit.;

Détails

Origin ID

81420-2;

UMLS CUI

C4265357;

Has component
- Gene [LOINC component]
- KRAS & NRAS gene targeted mutation analysis [LOINC component]
- KRAS and NRAS gene [LOINC component]
- NRAS gene [LOINC component]
- NRAS gene targeted mutation analysis [LOINC component]
Has method
- Molecular genetics [LOINC method]
Has property
- Presence or Identity [LOINC Property]
Has scale
- Nom [LOINC scale]
Has system
- Blood [LOINC System]
- Blood or Tissue [LOINC System]
- Tissue and Smears [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients